Virological and metabolic outcomes after switching to dolutegravir or rilpivirine in virologically suppressed adults with HIV in Thailand: an open-label, randomised, controlled, non-inferiority trial
- DOI
- 10.1016/j.lansea.2026.100862
- Published
- 2026-10
- Container
- The Lancet Regional Health - Southeast Asia
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.lansea.2026.100862,
title = {Virological and metabolic outcomes after switching to dolutegravir or rilpivirine in virologically suppressed adults with HIV in Thailand: an open-label, randomised, controlled, non-inferiority trial},
author = {Rattagan Kajeekul and Narisa Ruenroengbun and Sirichai Wiwatrojanagul and Kannarin Kirdtongkum and Walinda Chantaranothai and Khairil Erwan Bin Khalid and Rujipas Sirijatuphat and Thundon Ngamprasertchai},
year = {2026},
journal = {The Lancet Regional Health - Southeast Asia},
doi = {10.1016/j.lansea.2026.100862},
url = {https://doi.org/10.1016/j.lansea.2026.100862}
}RIS
TY - JOUR TI - Virological and metabolic outcomes after switching to dolutegravir or rilpivirine in virologically suppressed adults with HIV in Thailand: an open-label, randomised, controlled, non-inferiority trial AU - Rattagan Kajeekul AU - Narisa Ruenroengbun AU - Sirichai Wiwatrojanagul AU - Kannarin Kirdtongkum AU - Walinda Chantaranothai AU - Khairil Erwan Bin Khalid AU - Rujipas Sirijatuphat AU - Thundon Ngamprasertchai PY - 2026 JO - The Lancet Regional Health - Southeast Asia DO - 10.1016/j.lansea.2026.100862 UR - https://doi.org/10.1016/j.lansea.2026.100862 ER -
APA
Kajeekul, R., Ruenroengbun, N., Wiwatrojanagul, S., Kirdtongkum, K., Chantaranothai, W., Khalid, K. E. B., Sirijatuphat, R., & Ngamprasertchai, T. (2026). Virological and metabolic outcomes after switching to dolutegravir or rilpivirine in virologically suppressed adults with HIV in Thailand: an open-label, randomised, controlled, non-inferiority trial. The Lancet Regional Health - Southeast Asia. https://doi.org/10.1016/j.lansea.2026.100862
Source records
- crossref · retrieved 2026-09-25T14:49:41.879Z